A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197

PHASE2TerminatedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Psoriatic Arthritis
Interventions
DRUG

ABT-122

Injection

Trial Locations (36)

1027

Site Reference ID/Investigator# 138959, Budapest

1463

Site Reference ID/Investigator# 138928, Sofia

Site Reference ID/Investigator# 138930, Sofia

1505

Site Reference ID/Investigator# 138929, Sofia

2025

Site Reference ID/Investigator# 138986, Auckland

4002

Site Reference ID/Investigator# 138925, Plovdiv

Site Reference ID/Investigator# 138926, Plovdiv

4003

Site Reference ID/Investigator# 138927, Plovdiv

4102

Site Reference ID/Investigator# 138922, Woolloongabba

6021

Site Reference ID/Investigator# 138987, Newtown, Wellington

7010

Site Reference ID/Investigator# 138988, Nelson

15702

Site Reference ID/Investigator# 139020, Santiago de Compostela

23538

Site Reference ID/Investigator# 138953, Lübeck

60528

Site Reference ID/Investigator# 141365, Frankfurt

68601

Site Reference ID/Investigator# 138932, Uherské Hradiště

540136

Site Reference ID/Investigator# 139016, Targu-Mures, Jud. Mures

140 00

Site Reference ID/Investigator# 138934, Prague

150 06

Site Reference ID/Investigator# 138933, Prague

LV-2164

Site Reference ID/Investigator# 138983, Ādaži

LV-1012

Site Reference ID/Investigator# 138985, Riga

LV1011

Site Reference ID/Investigator# 138982, Riga

LV-4201

Site Reference ID/Investigator# 138984, Valmiera

15-879

Site Reference ID/Investigator# 139000, Bialystok

85-168

Site Reference ID/Investigator# 139012, Bydgoszcz

82-300

Site Reference ID/Investigator# 138999, Elblag

40-748

Site Reference ID/Investigator# 139007, Katowice

31-637

Site Reference ID/Investigator# 139006, Krakow

20-582

Site Reference ID/Investigator# 139005, Lublin

32-600

Site Reference ID/Investigator# 139026, Oświęcim

60-218

Site Reference ID/Investigator# 139004, Poznan

37-450

Site Reference ID/Investigator# 139001, Stalowa Wola

70-332

Site Reference ID/Investigator# 139011, Szczecin

87-100

Site Reference ID/Investigator# 139003, Torun

51-685

Site Reference ID/Investigator# 139010, Wroclaw

011172

Site Reference ID/Investigator# 139013, Bucharest

03203

Site Reference ID/Investigator# 139022, Elche

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY